IGG4-RD

Clinical trials for IGG4-RD explained in plain language.

Never miss a new study

Get alerted when new IGG4-RD trials appear

Sign up with your email to follow new studies for IGG4-RD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Halted trial tests new drug for mysterious Multi-Organ disease

Disease control Terminated

This study tested whether adding the drug elotuzumab to standard steroid treatment (prednisone) could better control IgG4-Related Disease (IgG4-RD), a chronic condition that causes inflammation and scarring in various organs. It involved about 75 adults with active disease affect…

Matched conditions: IGG4-RD

Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

IGG4-RD

Get alerted when new IGG4-RD trials appear

Halted trial tests new drug for mysterious Multi-Organ disease